title: Single or tandem high-dose chemoradiotherapy with autologous stem-cell support (HDC/AUSCS) for resistant multiple myeloma.
mesh_terms: D054598:Blue Cross Blue Shield Insurance Plans; D017024:Chemotherapy, Adjuvant; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000532:radiotherapy*; D017063:Outcome Assessment, Health Care; D018714:Radiotherapy, Adjuvant; D013673:Technology Assessment, Biomedical; D014481:United States